IPCA Laboratories P/E Ratio

Current P/E Ratio
40.82
High Valuation
Very High - High growth expectations or significantly overvalued

IPCA Laboratories (IPCALAB) P/E ratio is 40.82 (High), EPS (TTM) ₹44.98, current price ₹1762.70 on NSE vs historical average P/E of 29.71 (71.4th percentile) — Very High - High growth expectations or significantly overvalued. Read IPCALAB dividend growth for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/E Ratio 40.82
Current Price ₹1762.70
EPS (TTM) ₹44.98
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 29.71
Historical Range 6.77 - 52.19
Percentile 71.4%

Sector Context

Sector Average 55.72
Sector Median 31.4
Sector Rank #11 of 194
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹36.31
Mar 2026 ₹13.31
Sept 2025 ₹11.14

IPCALAB P/E Ratio — Valuation Signal & Historical Context

IPCA Laboratories P/E 40.82 vs historical average 29.71, range 6.77–52.19 — signal: Overvalued. See IPCALAB price to book ratio to compare market price against book value per share.

  • Stock appears overvalued with PE of 40.82, suggesting caution for new investments
  • Current PE is 37.4% above historical average
  • Trading at discount to sector average PE of 55.72

IPCA Laboratories P/E Ratio Historical Trend

IPCALAB annual price-to-earnings ratio — 7 years, EPS and year-end price. Current P/E 40.82 vs historical average 29.71. For live price, revenue and the complete fundamental profile, see IPCA Laboratories stock price NSE.

IPCALAB Historical P/E Ratio — EPS, Year-End Price & Valuation

IPCA Laboratories annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 47.21 35.86 ₹1692.95 NSE High
2024 38.92 28.76 ₹1119.35 NSE High
2023 37.6 22.25 ₹836.70 NSE High
2022 52.19 20.69 ₹1079.80 NSE High
2021 16.93 64.38 ₹1090.00 NSE Moderate
2020 6.77 84.04 ₹569.15 NSE Low
2019 8.37 48.79 ₹408.15 NSE Low

IPCALAB vs Healthcare Peers — P/E Ratio Comparison

IPCA Laboratories P/E 40.82 vs Healthcare average 55.72, median 31.4 — range 2.86–916.67.

Sector Average
55.72
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.61 ₹64 Low
Sunrest Lifescience SUNREST 3.76 ₹30 Low
Sun Pharma Advanced Rese… SPARC 4.76 ₹7,399 Low
Shelter Pharma SHELTER 5.23 ₹47 Low
Dipna Pharmachem DPL 5.39 ₹14 Low
JFL Life Sciences JFLLIFE 5.41 ₹68 Low
Amwill Health Care AMWILL 7.26 ₹83 Low
Zenith Drugs ZENITHDRUG 7.69 ₹84 Low
Galaxy Medicare GML 7.8 ₹27 Low